Avtal | $24,000,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026)
Certified by Founder
Lodge
Alida Biosciences
start up
United States
- San Diego
- 13/06/2024
- Series A
- $7,500,000
Alida Biosciences is developing the next generation of RNA analysis tools to enable new medical treatments and diagnostic assays.
- Industry Biotechnology Research
- Website https://alidabio.com/
- LinkedIn https://www.linkedin.com/company/alida-biosciences/
Related People
Gudrun StengelFounder
United States -
San Diego, California
Strategic leader and product developer with track record in the commercialization of assays, reagents and integrated platforms for biomedical applications. Specialized in -omics applications.
Latent | $80,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Edra | $30,000,000 | (Mar 20, 2026)
Chalkie AI | $4,000,000 | (Mar 20, 2026)
Deeptune | $43,000,000 | (Mar 20, 2026)
SetSale | $2,000,000 | (Mar 19, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)